Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

  40,287,245      
Direct Value   $128,455,406    

Indirect Value

  $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $36,379,020 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $4,228,491 Achieve Life Sciences Inc
 $4,404,511 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $118,601 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,218,584 ReShape Lifesciences Inc
 $831,407 Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $36,379,020 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $4,228,491 Achieve Life Sciences Inc
 $4,404,511 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $118,601 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $20,218,584 ReShape Lifesciences Inc
 $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    99   
    96    

     Stock price went up :

    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

Download
  Page 25 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VXRT Vaxart Inc Director   –       •      –    2020-06-03 4 S $2.77 $1,108,000 D/D (400,000) 7,000,000 0 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-05 4 B $2.77 $69,295 I/I 25,000 39,225,000 1.5 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-08-18 4 B $2.78 $55,550 I/I 20,000 39,300,000 2.25 %
VXRT Vaxart Inc Director   –       •       •   2020-05-11 4 S $2.79 $3,627,000 D/D (1,300,000) 14,400,000 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-15 4 S $2.82 $1,293,362 D/D (458,639) 11,000,000 0 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-06 4 B $2.83 $70,630 I/I 25,000 39,250,000 1.5 %
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $2.85 $134,821 D/D (47,182) 796,594 0 -
VXRT Vaxart Inc Director   –       •       •   2020-05-18 4 S $2.86 $1,859,000 D/D (650,000) 10,350,000 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-22 4 S $2.86 $572,000 D/D (200,000) 8,600,000 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-09-06 4 B $2.95 $2,950,000 D/D 1,000,000 20,683,233 3.92 -
VXRT Vaxart Inc Director   –       •       •   2020-04-30 4 S $2.96 $13,125,516 D/D (4,434,296) 18,600,000 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-13 4 S $2.97 $1,561,080 D/D (525,616) 12,293,308 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-21 4 S $2.97 $1,188,000 D/D (400,000) 8,800,000 0 %
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-29 4 S $3.00 $1,200,000 I/I (400,000) 1,045,963 0 -
VXRT Vaxart Inc Director   –       •       •   2020-04-29 4 S $3.01 $2,629,638 D/D (873,634) 23,034,296 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-12 4 S $3.02 $4,774,850 D/D (1,581,076) 12,818,924 0 %
VXRT Vaxart Inc Director   –       •       •   2020-05-14 4 S $3.02 $2,520,700 D/D (834,669) 11,458,639 0 %
KPRX Kiora Pharmaceuticals Director   –       •       •   2019-09-30 4 B $3.11 $15,613 D/D 5,001 1,792,500 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-28 4 B $3.12 $82,677 D/D 26,499 18,116,499 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-09-04 4 B $3.13 $3,756,000 D/D 1,200,000 19,683,233 3.92 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2019-09-29 4 B $3.13 $1,875,000 D/D 600,000 1,787,499 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-31 4 B $3.18 $39,081 D/D 12,300 18,128,799 3.92 -
VXRT Vaxart Inc Director   –       •       •   2020-05-20 4 S $3.19 $3,668,500 D/D (1,150,000) 9,200,000 0 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-12 4 B $3.20 $44,704 I/I 13,970 313,970 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-29 4 B $3.21 $55,125 D/D 17,173 18,458,642 3.92 -

  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25  26   27   28   29   30   31   32      
  Page 25 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed